| Lipoprotein (a): A Potential Biological Marker for Unruptured Intracranial Aneurysms Phillips J, Roberts G, Bolger C, el Baghdady A, Bouchier-Hayes D, Farrell M ... Neurosurgery 40, 1112-117, 1997 | 53 | 1997 |
| Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized … R Oliver, JG Krueger, S Glatt, P Vajjah, C Mistry, M Page, H Edwards, ... British journal of dermatology 186 (4), 652-663, 2022 | 35 | 2022 |
| Fluoxetine and Depression In-Patients with Idiopathic Parkinson's disease CML Foy, JM Graham, A el Baghdady, HJ Sagar 5th International Congress of Parkinson’s Disease and Movement Disorders …, 1998 | 3* | 1998 |
| ARC-12: Phase 1/1b Study to Evaluate Safety and Tolerability of AB308+ Zimberelimab (AB122) in Advanced Malignancies S Ailawadhi, P Foster, S Ryba, M Scharville, A El-Baghdady Blood 138, 1409, 2021 | 1 | 2021 |
| Unlocking the Market Potential of Academic Research Assem S el Baghdady, Yasser el Baghdady Collaborative Innovation in Drug Discovery, 221-253, 2014 | 1* | 2014 |
| Overview of Clinical Development of Monoclonal Antibodies AS el Baghdady Monoclonal Antibodies: History, Mechanism and Application, Chapter 6, 2022 | | 2022 |
| ARC-12: Phase I/Ib dose escalation and dose expansion study to evaluate the safety and tolerability of AB308 + zimberelimab (AB122) in advanced malignancies AP J.A. Call, M.A. Mckean, P. Foster, C. Trudeau, M. Scharville, A. El-Baghdady Annals of Oncology 32 ((suppl_5) S829-S866. 10.1016/annonc/), 2021 | | 2021 |
| 1028TiP ARC-12: Phase I/Ib dose escalation and dose expansion study to evaluate the safety and tolerability of AB308+ zimberelimab (AB122) in advanced malignancies JA Call, MA Mckean, P Foster, C Trudeau, M Scharville, A El-Baghdady, ... Annals of Oncology 32, S861-S862, 2021 | | 2021 |
| Clinical Trials of Medicines in the Elderly Assem S el Baghdady Clinical Research Manual, 20.1 - 20.23, 2017 | | 2017 |
| Successful Technology Transfer: Lessons from the Translational Medicine Research Collaboration Assem S el Baghdady Collaborative Innovation in Drug Discovery, 563-575, 2014 | | 2014 |
| Book Review: Principles and Practice of Pharmaceutical Medicine (Stonier, Peter) AS el Baghdady Journal of Pharmaceutical Physician, 2010 | | 2010 |
| Quetiapine Monotherapy for the Treatment of Acute Mania Associated with Bipolar Disorder M Brecher, A el Baghdady Nordic Psychiatric Association, Reykjavík, Iceland, 2003 | | 2003 |
| Quetiapine Adjunctive Therapy for Acute Mania Associated with Bipolar Disorder Jamie Mullen, el Baghdady A Nordic Psychiatric Association, Reykjavík, Iceland, 2003 | | 2003 |
| Book Review: Evaluation and Management of Gait Disorder (Barney S. Spivack) AS el Baghdady Journal of Behavioural Neurology 11 (Part 4), 265-266, 1999 | | 1999 |
| Fluoxetine and Motor Control In-Patients with Idiopathic Parkinson's disease CML Foy, A el Baghdady, HJ Sagar 5th International Congress of Parkinson’s Disease and Movement Disorders …, 1998 | | 1998 |
| Lipoprotein (a): A Potential Biological Marker for Unruptured Intracranial Aneurysms Philips J, Roberts G, Bolger C, el Baghdady A, Bouchier-Hayes D, Farrell M ... Society of British Neurological Surgeons Meeting, Cambridge, UK, 1997 | | 1997 |
| A Controlled Comparison StudThe Effect of Pergolide and Bromocriptine on Motor Control in Idiopathic Parkinson’s Disease el Baghdady AS, Grünewald RA, Sagar HJ Association of British Neurologist, University of Leicester, Leicester, UK …, 1997 | | 1997 |
| Elevated Levels of Lipoprotein (a) in Association with Cerebrovascular Saccular Aneurysmal Disease in First Degree Relatives Philips J, Roberts G, Bolger C, el Baghdady A, Bouchier-Hayes D, Farrell M Society of British Neurological Surgeons Meeting, Preston, UK, 1996 | | 1996 |
